default author photo

Paola Del Bianco

Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS)

SCHOLARLY PAPERS

1

DOWNLOADS

29

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

Number of pages: 10 Posted: 07 Jan 2026
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Università degli Studi di Bari “Aldo Moro” (UNIBA), affiliation not provided to SSRN, Humanitas Gavazzeni, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Ferrara, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - IRCCS Veneto Institute of Oncology (IOV-IRCCS), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Padova - Department of Cardiac, Thoracic, Vascular Science and Public Health, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 29 (1,332,057)

Abstract:

Loading...

Pleural Mesothelioma, Immunotherapy, perioperative, pleurectomy, multimodality